1,250 research outputs found
Psychosocial Risk Factors and Psychopathological Outcomes: Preliminary Findings in Italian Pregnant Women
The perinatal period may represent a particularly challenging time for expecting parents. Previous studies have highlighted an association between several perinatal risk conditions (e.g., childhood maltreatment, poor social support, and stress levels) and the development of psychopathological symptoms in pregnant women, especially depression symptoms. The current study examined the effects of psychosocial risk factors (childhood maltreatment, poor social support, and stressful events) on anxiety, depression, perceived stress, irritability/anger, relationship problems, psychosomatic symptoms, specific physiological problems, and addiction/at-risk behaviors. Sixty-one pregnant women (age range = 24–45) participating in a larger study completed questionnaires about childhood maltreatment (CECA Q.), Maternity Social Support Scale (MSSS), questionnaire on stressful events, and the Perinatal Assessment of Maternal Affectivity (PAMA) during their pregnancy. Results from regression analysis indicated that the presence of childhood maltreatment predicted elevated depressive symptoms, elevated irritability and anger, and elevated relationship problems. Further, stressful events in the year prior to pregnancy predicted elevated psychosomatic symptoms during pregnancy. No other significant associations were found. In this study, traumatic childhood events were strongly associated with mental health symptoms during pregnancy. This is an important finding that suggests the importance of screening and targeting psychotherapeutic interventions for vulnerable women during pregnancy
Application of lead time analysis as a method in EU co-funded mid-term programme evaluations in 2007-13: the case of Bulgaria and Malta
Working with children who are victims of abuse: Emotions and representations of professionals in residential children's communities
Professionals who work in residential children's communities face many difficulties and, when the hosted children have a history of abuse and maltreatment, the risk of vicarious traumatization and professional burn-out, which has a negative effect on the professional's work and well-being as well as on the effectiveness at work, is very high. This qualitative study aims to explore, via the content analysis of text recorded in some Photolangage® groups, the representations of social workers and educators in residential children's communities on the theme of work management of physical and sexual abuse victims. The participants were 37 social workers from 6 residential communities for 0-6 years old child in the region of Palermo (Italy). The analysis of the discourse revealed four main themes: "emotional responses", "difficulty in coping with emotions related to abuse", "relationship with the institutional network" and "work methods/strategies", which seem to guide and inform the social workers in our daily relationship with children. These results, which are in line with clinical observations, indicate the importance of supporting, through tools such as supervision and analysis of professional practices, professionals who work with maltreated and abused children, the only way to protect their well-being and the "therapeutic role" in the care and protection of children which they fulfil
Immunoistochemical expression of PD-1 and PD-L1 in bone marrow biopsies of patients with acute myeloid leukemia
Background. Haematological and non-haematological malignancies are able to escape the host immune by the capacity to hijack the immune check-points. Several immune check-point molecules are known, such as T cell immunoglobulin mucin-3 (TIM-3), cytotoxic T-cell antigen-4 (CTLA-4), programmed death-1 (PD-1) with its ligand PD-L1 and others.1 The function of these immune check-points is to prevent the damage resulting from an excessive activation of the immune response in the setting of chronic antigenic stimulation, thus leading to autoimmune phenomena, as proved in knock-out mice models. PD-1 is normally present on activated T lymphocytes membrane, acting as a negative costimulatory receptor. PD-L1 is constitutively expressed at low levels by resting lymphocytes, antigen presenting cells and certain immunologically privileged tissues like placenta and testis. PD-L1 expression can be induced as well. In an inflammatory/infective context when T cells recognize antigens expressed by MHC-complex they start to produce inflammatory cytokines. The resulting inflammation leads to the expression of PD-L1 by hematopoietic, epithelial and endothelial cells, activating PD-1 on the surface of T-cells and therefore blocking the immune response. Previous studies have found out that PD-1 is highly expressed on T-reg cells and their binding with PD-L1 enhances suppressor T-reg functions2,3; the activation of PD-1/PD-L1 pathway reduces the lytic capacity of NK cells and B cell antibody production. In solid neoplasms PD-L1 expression by cancer cells and persistent up-regulation of PD-1 by tumourinfiltrating lymphocytes is common45. All these findings brought to the development of check-point inhibitors in the contest of solid tumors and lymphoproliferative neoplasms such as lymphoma and myeloma where the immune checkpoint blockade treatment have shown efficacy in refractory/relapsed neoplasms6. Few investigations only have been conducted on the role of PD1/PD-L1 in myeloid neoplasms, such as acute myeloid leukemia, a haematological cancer characterised by high-risk of relapse and poor prognosis. In leukemia, the bone marrow serves as a sanctuary for neoplastic cells, these cells interact with the tumour microenvironment (TME), constituted by stromal cells, endothelial cells and immune cells. The marked activation of the PD-1/PD-L1 pathway contributes to the maintenance of an immunosuppressive microenvironment. In fact, blasts are able, through the production of immunoinhibitory factors, to suppress the function of immunosurveillance and immuno-elimination of the tumor by the effector T cells. The effector T cells are "exhausted" in their capacity to secrete granzyme B, perforine and interferon gamma, and there is an upregulation of the T-reg functions, in addition to the presence of myeloid-derived suppressor cells7. PD-L1 expression and his link with PD-1 on activated lymphocytes results in an impaired antitumoral activity in murine models8. Zhang et al. investigated the role of PD-1/PD-L1 engagement in murine AML showing that PD-1-/-mice generated augmented antitumoral response in comparison with wild type mice. Similar results were obtained using anti-PD-L1 antibodies.9 A study from Zhou et al. reported how the function of adoptively transferred AML-reactive CTLs was reduced by AML-associated Tregs and how Treg depletion followed by PD-1/PD-L1 blockade showed efficacy for AML eradication in murine models.10 Objective of the study. To assess the presence of PD-1 and PD-L1 positive cells, by immunohistochemistry, in bone marrow biopsies of patients with AML. Material and methods. Four micron thickness sections were obtained from the formalin-fixed paraffin-embedded specimens. Haematoxylin-eosin staining was performed to assess the morphologic features of bone marrow. Immunohistochemical stainings were performed using a Ventana Benchmark Ultra automated staining instrument according to the manufacturer’s recommendations, using anti-PD-1 (clone NAT105, Ventana) and anti-PD-L1 (clone 22C3, Dako) antibodies. Results. We obtained 34 bone marrow trephine biopsies from newly diagnosed AML patients, 17 males and 17 females with a 67.3 mean age. We used 10 healthy bone marrow specimens as normal controls. None out of 10 control bone marrows resulted positive for either PD-1 or PD-L1 expressing cells as expected. Eleven out of 34 AML bone marrows (32,4%) showed at least 1% of PD-L1 positive cells (fig.2 b,d,f), while 6 AML bone marrow samples (17,6%) were positive for at least 1% of PD-1+ cells (fig. 1 b). Discussion. Despite the presence of relevant preclinical data regarding the role of immune check-points, few studies to evaluate the PD1/PDL1 axis have been conducted in myeloid neoplasm. Jia et al. performed flow cytometry analysis on PBMCs and BMMCs of 22 newly diagnosed AML patients and observed a significantly increased frequency of PD-1 expressing CD8 T cells in bone marrow compared to peripheral blood, suggesting a more exhausted status of these cells in relation to the suppressivePaper environment11. Dail et al. measured PD-L1 expression in 7 AML patients using immunohistochemistry and flow cytometry and found that PD-L1 was detectable (>2% cells) in all patients.12 Yang et al. assessed 45 bone marrow biopsies of MDS, CMML and AML patients and found that leukemic blasts of 9 patients (20%) were PD-L1+, while 3 (7%) were positive for PD-1. All 4 controls tested were negative for both PD-1 and PD-L1.13 Daver et al. measured PD-1 expression on bone marrow aspirates of 74 AML patients using flow cytometry. The results showed higher PD-1 expression compared to healthy controls (n=8).14Acceped To our this is the largest study evaluating by immunohistochemistry the expression of PD-1 and PDL1 in AML bone marrows and shows a significative positivity of the activation of the PD-1/PD-L1 pathway which gives a rationale to further studies regarding the charateristics of the cells involved in the PD-1/PD-L1 pathway and the immunosuppressive microenvironment. An implementation of the PD-1/PD-L1 pathway evaluation in clinical setting could have prognostic significance since the expression of PD-L1 by AML blasts has been associated with poor-risk and intermediate-risk AML15, furthermore immune checkpoint inhibitors have shown promising results in maintenance treatment of high-risk AML16, underlining not only a prognostic but also therapeutic value of the PD1/PD-L1 evaluation
Role of the CipA Scaffoldin Protein in Cellulose Solubilization, as Determined by Targeted Gene Deletion and Complementation in Clostridium thermocellum
The CipA scaffoldin protein plays a key role in the Clostridium thermocellum cellulosome. Previous studies have revealed that mutants deficient in binding or solubilizing cellulose also exhibit reduced expression of CipA. To confirm that CipA is, in fact, necessary for rapid solubilization of crystalline cellulose, the gene was deleted from the chromosome using targeted gene deletion technologies. The CipA deletion mutant exhibited a 100-fold reduction in cellulose solubilization rate, although it was eventually able to solubilize 80% of the 5 g/liter cellulose initially present. The deletion mutant was complemented by a copy of cipA expressed from a replicating plasmid. In this strain, Avicelase activity was restored, although the rate was 2-fold lower than that in the wild type and the duration of the lag phase was increased. The cipA coding sequence is located at the beginning of a gene cluster containing several other genes thought to be responsible for the structural organization of the cellulosome, including olpB, orf2p, and olpA. Tandem mass spectrometry revealed a 10-fold reduction in the expression of olpB, which may explain the lower growth rate. This deletion experiment adds further evidence that CipA plays a key role in cellulose solubilization by C. thermocellum, and it raises interesting questions about the differential roles of the anchor scaffoldin proteins OlpB, Orf2p, and SdbA
Release of Selected Non-Intentionally Added Substances (NIAS) from PET Food Contact Materials: A New Online SPE-UHPLC-MS/MS Multiresidue Method
- …